INTERVIEWS

Dr. Amit Kumar discusses the partnership with the Cleveland Clinic to develop an experimental vaccine for breast cancer.

John Termini recently presented his finding at the American Chemical Society annual meeting about how diabetes increases cancer risks.

The Optimized Patient: How to Prepare for, Survive, and Recover from Spine or Other Major Surgeries.

Michael Spigler discusses the American Kidney Fund‘s Beyond Bananas™ campaign supported by AstraZeneca. This campaign works as a resource for hyperkalemia patients while also raising awareness about high potassium and that it doesn’t just come from bananas and is a condition that must be closely monitored.

Lara Merriken founder of Larabar joins us to share how she stays fueled with real food while on the go, the importance of plant proteins and real food goodness.

Cellectis has pioneered the “off-the-shelf” approach to gene editing CAR T-cells to treat cancer and other genetic diseases. Dr. André Choulika discusses how this approach allows treatments to be produced by the thousands from healthy donor cells (versus the patient’s own cells), stored long-term, provided to hospitals around the world and given to any patient who is in medical need. Off-the-shelf gene editing marks the next transformative step in medicine, and Cellectis has the first U.S. clinical trials underway now.

CEO of Esperion, Tim Mayleben, speaks to the need for more therapies/options in the cholesterol-lowering space.

The spotlight this month is firmly on bone health for healthcare practitioners. Osteoporosis is a common disease affecting over 1 million Australians. (1) Building and maintaining bone health is not something to only consider for older patients. Bone mass begins to decline at 35 years of age. (2) Building on the ‘bone bank’ is important for optimal long-term bone health and as we age it becomes critical in addressing bone mass loss. (3)

Jeffrey Kraws discusses DABRA with the minimally invasive Pharos Excimer Laser for the treatment of vascular and skin diseases.

Tomosynthesis system technology that creates 3D images that enable surgeons to identify healthy tissue in breast cancer surgery.